Cidara Therapeutics
CDTX
CDTX
54 hedge funds and large institutions have $34.4M invested in Cidara Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.34% less ownership
Funds ownership: 1.86% → 1.52% (-0.34%)
4% less call options, than puts
Call options by funds: $44K | Put options by funds: $46K
Holders
54
Holding in Top 10
1
Calls
$44K
Puts
$46K
Top Buyers
| 1 | +$937K | |
| 2 | +$846K | |
| 3 | +$774K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$762K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$469K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$522K | |
| 3 | -$399K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$228K |
| 5 |
AG
Artal Group
Luxembourg
|
-$170K |